EP3052628
Samsetningar og aðferðir til að hamla tjáningu ALAS1 gensins
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.10.2014EP published:
26.2.2020EP application number:
14800179.5
EP translation filed:
26.5.2020Grant published:
15.6.2020EPO information:
European Patent Register
Max expiry date:
2.10.2034Expiry date:
2.10.2026Next due date:
31.10.2026
Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
Timeline
Today
3.10.2014EP application
26.2.2020EP Publication
26.5.2020Translation submitted
15.6.2020Registration published
2.10.2026Expires
Owner
Name:
Alnylam Pharmaceuticals, Inc.Address:
300 Third Street, Cambridge, MA 02142, US
Name:
Icahn School of Medicine at Mount SinaiAddress:
One Gustave L. Levy Place, New York, NY 10029, US
Inventor
Name:
BETTENCOURT, BrianAddress:
Cambridge, MA 02142, US
Name:
FITZGERALD, KevinAddress:
Cambridge, MA 02142, US
Name:
QUERBES, WilliamAddress:
Cambridge, MA 02142, US
Name:
DESNICK, Robert, J.Address:
New York, NY 10128, US
Name:
YASUDA, MakikoAddress:
New York, NY 10040, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361887288 PDate:
4.10.2013Country:
US
Number:
201461983720 PDate:
24.4.2014Country:
US
Supplementary protection
SPC number:
SPC312
Classification
Categories:
C12N 15/113, A61K 31/7088, A61K 31/713, A61P 3/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 18.9.2020
Expires: 2.10.2021
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 20.9.2021
Expires: 2.10.2022
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 20.9.2022
Expires: 2.10.2023
Payer: Patice ehf.
Number: 10
Paid: 31.10.2023
Expires: 2.10.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 23.9.2024
Expires: 2.10.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 24.10.2025
Expires: 2.10.2026
Payer: Árnason Faktor ehf.